XWEL · XWELL, Inc.
$0.98
-0.03 (-2.97%)
At close · Aug 14
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“While the Company has suffered recurring losses and negative cash flows from operations, management evaluated whether substantial doubt existed about the Company’s ability to continue as a going concern within one year after the date these unaudited condensed consolidated financial statements are issued. ... Based on its current cash position and expected operating cash flows, the Company believes it has sufficient liquidity to fund its operations and meet its obligations for at least the next twelve months.”View the 10-Q filed Aug 14, 2026
Market Cap
$8.42M
Shares
8.59M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$29.21M
-13.8%
FY2025
Net Income
-$16.99M
-0.8%
FY2025
Gross Margin
25.7%
-0.6pp
FY2025
Operating Margin
-53.65%
-4.4pp
FY2025
Diluted EPS
-$5.08
-38.8%
FY2025
Operating Cash Flow
-$8.71M
+20.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $28.28M | $29.21M | $33.9M | $30.11M | $55.94M | $73.73M | $8.39M | $48.52M | $50.09M | $48.82M | $11.99M | $22.69M | $1.43M | $1.1M | $100K | $718K | $211K | — | — | — | — | |
| $424K | $661K | $380K | $448K | $384K | $43K | -$1.83M | -$2.9M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $18.57M | $21.7M | $24.98M | $26.43M | $43.89M | $41.39M | $11.98M | $37.85M | $39.45M | $38.99M | $6.74M | $800K | $0 | — | $12.51M | $155K | $180K | — | — | — | — | |
| $9.71M | $7.51M | $8.92M | $3.68M | $12.05M | $32.34M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | 25.7% | 26.31% | 12.23% | 21.54% | 43.87% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | $889K | $1.51M | $543K | $2.02M | $2.5M | — | — | — | — | |
| $4.16M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $2.78M | $1.84M | — | — | — | — | |
| $19.65M | $16M | $20.08M | $12.96M | $21.18M | $24.2M | $15.94M | $14.32M | $16.24M | $16.58M | $9.7M | $10.16M | $16.37M | $15.33M | $10.23M | — | — | — | — | — | — | |
| — | $302K | $316K | — | — | — | — | — | — | — | — | $3.3M | $3.77M | $3.45M | $1.69M | — | — | — | — | — | — | |
| $844K | $862K | $938K | $2.07M | $5.43M | $3.2M | $5.21M | $6.12M | $7.4M | $7.98M | $1.32M | $3.52M | $255K | $87K | $46K | $1000 | $87K | — | — | — | — | |
| $27.05M | $23.18M | $25.63M | $31.89M | $43.21M | $28.24M | $48.49M | $64.39M | $84.82M | $63.54M | $29.69M | $33.03M | $112.62M | $41.88M | $22.47M | $7.14M | $6.71M | — | — | — | — | |
| -$17.34M | -$15.67M | -$16.71M | -$28.21M | -$31.16M | $4.11M | -$40.1M | -$15.87M | -$34.73M | -$14.72M | -$17.71M | -$10.34M | -$111.2M | -$40.78M | -$22.37M | -$6.42M | -$6.5M | — | — | — | — | |
| — | -53.65% | -49.29% | -93.68% | -55.71% | 5.57% | -478.28% | -32.72% | -69.32% | -30.14% | -147.74% | -45.59% | -7803.23% | -3707% | -22371% | -894.71% | -3078.2% | — | — | — | — | |
| -$16.49M | -$14.81M | -$15.77M | -$26.14M | -$25.73M | $7.31M | -$34.89M | -$9.75M | -$27.33M | -$6.74M | -$16.39M | -$6.83M | -$110.94M | -$40.69M | -$22.33M | -$6.42M | -$6.41M | — | — | — | — | |
| $2.7M | — | — | — | — | — | — | $2.9M | $1.83M | $731K | $1.7M | $2.59M | $0 | — | — | — | — | — | — | — | — | |
| -$155K | -$167K | -$211K | -$355K | -$1.13M | -$1.18M | $858K | -$4.07M | -$1.18M | -$1.29M | -$1.57M | -$1.78M | $1.97M | — | — | — | — | — | — | — | — | |
| — | $27K | $35K | -$54K | -$618K | -$1.05M | $1.29M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $174K | $61K | $356K | $857K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$22.32M | -$16.08M | -$16.44M | -$27.99M | -$32.57M | $2.95M | -$92.23M | -$20.68M | -$35.91M | -$16M | -$19.28M | -$12.12M | -$109.22M | -$41.75M | -$18.41M | -$7.39M | -$9.91M | — | — | — | — | |
| — | $29K | $49K | $35K | $55K | $56K | $7000 | -$146K | -$278K | $111K | $0 | -$866K | $0 | $0 | $0 | $0 | $35K | — | — | — | — | |
| -$23.58M | -$16.99M | -$16.85M | -$27.74M | -$32.84M | $3.35M | -$90.49M | -$21.22M | -$37.21M | -$28.84M | -$24.01M | -$11.16M | -$109.68M | -$52.43M | -$20.84M | -$7.48M | -$9.94M | -$6.15M | -$7.33M | -$5.16M | -$1.48M | |
| — | -58.17% | -49.72% | -92.14% | -58.7% | 4.54% | -1079.17% | -43.75% | -74.27% | -59.07% | -200.28% | -49.18% | -7696.63% | -4766.64% | -20841% | -1041.64% | -4711.85% | — | — | — | — | |
| $1.08M | $885K | $363K | -$288K | $208K | -$456K | -$1.74M | $693K | $459K | $451K | $3000 | -$101K | $0 | — | — | — | — | — | — | — | — | |
| -$33.32M | -$28.23M | -$16.85M | — | — | — | -$91.43M | -$21.22M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$22.62M | -$15.64M | -$16.42M | -$29.31M | -$32.85M | $2.8M | -$92.17M | -$20.56M | -$36.92M | -$28.45M | -$24.02M | -$11.26M | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | -$5.08 | -$3.66 | -$6.64 | -$7.01 | $0.60 | -$41.00 | — | — | -$77.40 | -$94.80 | -$65.40 | -$734.40 | -$37.80 | -$31.80 | — | — | — | — | — | — |
| USD/shares | — | -$5.08 | -$3.66 | -$6.64 | -$7.01 | $0.60 | -$41.00 | — | — | — | -$94.80 | -$65.40 | -$741.60 | -$37.80 | -$36.60 | — | — | — | — | — | — |
| shares | — | 5.56M | 4.61M | 4.18M | 4.68M | 5.22M | 2.23M | 81.72K | 24.23K | 18.57K | 252.79K | 170.3K | 149.4K | 1.39M | 651.85K | — | — | — | — | — | — |
| shares | — | 5.56M | 4.61M | 4.18M | 4.68M | 5.25M | 2.23M | 81.72K | 24.23K | 18.57K | 252.79K | 170.3K | 150.82K | 1.39M | 694.41K | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2012–FY2022: $31.61M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.32×
Peer median 1.32×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 9 similar-size Diagnostics & Research companies (of 49 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Xpresspa | $18,649,000 | $18,765,000 | $19,067,000 | $13,680,000 | $4,614,000 | — |
| Xpres Test | $8,249,000 | $13,055,000 | $9,912,000 | $40,867,000 | $69,078,000 | — |
| Naples Wax | $2,312,000 | $2,077,000 | $686,000 | — | — | — |
| Corporate And Other | — | — | — | — | — | $260,000 |
| Xpresspa | — | — | — | — | — | $8,045,000 |
| Xprestest | — | — | — | — | — | $80,000 |
| Treattm | — | — | $444,000 | $1,392,000 | $37,000 | — |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| United States | $23,420,000 | $27,813,000 | $24,944,000 | $52,250,000 | $71,114,000 | $7,051,000 |
| Non Us | $5,790,000 | $6,084,000 | $5,165,000 | — | — | — |
| All Other Countries | — | — | — | — | — | $1,334,000 |
| All Other Countries | — | — | — | $3,689,000 | $2,615,000 | — |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Service | $26,268,000 | $30,660,000 | $27,343,000 | $21,227,000 | $5,420,000 | $7,025,000 |
| Product | $2,942,000 | $3,237,000 | $2,766,000 | $1,930,000 | $763,000 | $1,004,000 |
| Administrative Service | — | — | — | — | $16,843,000 | — |
| Health Care Patient Service | — | — | — | $32,776,000 | $50,689,000 | — |
| Product And Service Other | — | — | — | $6,000 | $14,000 | $356,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Xpres Test | $4,314,000 | $5,192,000 | -$4,701,000 | $1,238,000 | $25,452,000 | — |
| Xpresspa | -$40,000 | -$12,301,000 | -$12,951,000 | -$12,910,000 | -$9,617,000 | — |
| Naples Wax | -$5,845,000 | -$496,000 | $162,000 | — | — | — |
| Corporate And Other | -$14,099,000 | -$9,102,000 | -$8,401,000 | -$8,914,000 | -$5,993,000 | -$6,644,000 |
| Xpresspa | — | — | — | — | — | -$29,966,000 |
| Xprestest | — | — | — | — | — | -$3,494,000 |
| Treattm | — | — | -$2,315,000 | -$10,577,000 | -$5,735,000 | — |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Xpresspa | -0.2% | -65.6% | -67.9% | -94.4% | -208.4% | — |
| Xpres Test | 52.3% | 39.8% | -47.4% | 3% | 36.8% | — |
| Naples Wax | -252.8% | -23.9% | 23.6% | — | — | — |
| Corporate And Other | — | — | — | — | — | -2555.4% |
| Xpresspa | — | — | — | — | — | -372.5% |
| Xprestest | — | — | — | — | — | -4367.5% |
| Treattm | — | — | -521.4% | -759.8% | -15500% | — |